MedTrace Logo

Post-Op Lidocaine Patch

NCT03500211 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-03-11

Study results available
· View outcomes & findings →

Summary

Randomized control trial evaluating use of lidocaine vs placebo patch for post-operative cesarean incision pain.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Lidoderm 5 % Topical Patch

Lidocaine patch after cesarean section delivery.

OTHER

Sham Topical Patch

Sham patch after cesarean section delivery.

Sponsors & Collaborators

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Catherine Leclair, MD · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-13
Primary Completion
2019-03-01
Completion
2019-03-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03500211 on ClinicalTrials.gov